申请人:The Methodist Hospital Research Institute
公开号:US20140323513A1
公开(公告)日:2014-10-30
Disclosed are compound for targeting chemotherapeutic agents to mammalian mitochondria. Also disclosed are monoamine oxidase-specific compositions, and methods of using them for the selective therapy of mammalian cancers, and in particular, in the treatment of human gliomas. Also disclosed are methods employing the novel targeted chemotherapeutics with one or more conventional anti-cancer therapies, including, for example, radiotherapy, or multi-drug regimens.
本发明涉及用于靶向化疗药物作用于哺乳动物线粒体的化合物。还公开了单胺氧化酶特异性组合物,以及使用它们进行哺乳动物癌症的选择性治疗的方法,特别是在人类胶质瘤的治疗中。还公开了使用新型靶向化疗药物与一种或多种常规抗癌疗法,包括放射治疗或多药物方案的方法。